tirzepatide surmount 3 Further Cements Weight Loss Benefit in SURMOUNT-3 and SURMOUNT-4 Trials tirzepatide phase 3 study results

Compared with sulfonylureas, metformin as first-line therapy has beneficial effects on A1C, is weight neutral, does not cause hypoglycemia, and reduces cardiovascular mortality (97)

Mounjaro is more likely to cost the full retail price without insurance, though some manufacturer savings cards and pharmacy discounts may still help lower out-of-pocket costs

Skibicka KP (2013) The central GLP-1: implications for food and drug reward

Research released by Eli Lilly reports that common side effects include nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, bloating, fatigue, and hair loss

It is also soon to be discontinued by Thorne